BioPharmaceutical Emerging Best Practices Association

2026 Hybrid European Bioassay Conference

19th Annual  |  Seville, Spain  |  23-25 September 2026
Hotel Meliá Sevilla

Registration Early Bird Prices:
Prices increase end-of-day April 24, 2026.

3-Day Event

Includes:

  • Bioassay Workshops
  • Scientific Poster Session
  • Two days of Podium Presentations
  • Two networking events

Group Discounts (only applicable to Industry tickets):

Quick Links

23-25 September 2026
Seville, Spain

Hybrid Conference

Deadlines

Abstract Submission: Feb. 20, 2026
Poster Submission: Sept. 2, 2026
Next Price Increase: Apr. 24, 2026
Registration Closes:
In-person closes Sept. 16, 2026
Virtual closes Sept. 18, 2026

Draft Agenda

Our Hybrid 2026 European Bioassay Conference draft agenda is here! Check the agenda for updates as we finalize our schedule.

Participating Companies:

  • Novartis
  • Sanofi
  • AstraZeneca
  • Richter BioLogics
  • Genmab
  • Eurofins
  • Promega
  • Stegmann Systems
  • acCELLerate
  • Bioassay GmbH

Hotel Information

A room block is reserved at the group rate of 180 EUR for a single, standard room and 200 EUR for a double, standard room per night. The room rates includes a buffet breakfast per person and 10% VAT per room. The room reservation deadline is Friday, 28 August 2026. After this date, reservations will be accepted on a space-available basis and at the best available rate. To make room reservations, please use the link provided below.

The room block will most likely be filled BEFORE the deadline; we recommend that attendees book their hotel accommodation well BEFORE the 28 August 2026 deadline. The Hotel Meliá Sevilla does require a credit card to guarantee your reservation. Reservations made for the hotel need to be cancelled 72 hours before your arrival for a full refund.

NOTE: Check-in time is 15:00 and check-out time is 12:00.

Hotel Meliá Sevilla

Calle Dr. Pedro de Castro, 1,
41004 Sevilla, Spain

Telephone: +34 954 42 15 11
Website: Meliá Sevilla

2026 EUB Exhibitors

2026 Planning Committee

Marie Gottar-Guiller
Novartis

Ulrike Herbrand
Charles River Labs

Sonja Klingelhoefer

Sonja Klingelhöfer
Richter Biologics

Alex Knorre
Eurofins

Pierre Lebrun
Pharmalex

Laureen Little

Laureen Little
BEBPA

Louise Pritchett
Novartis

Anton Stetsenko
BioQual Consulting

Lasse Waehrens
Novo Nordisk A/S